Thrombin-preconditioned Mesenchymal Stem Cell-Derived Exosomes For Wound Healing in vitro and in vivo

Background and ObjectivesThe skin is the largest organ of the human body, capable of protecting it from external harm. However, due to trauma, paralysis and other external factors, skin damage can occur, scars may form. Exosomes have regenerative functions and, as a cell-free therapy, show great potential for wound healing. In this study, we investigate that whether different umbilical cord mesenchymal stem cell exosomes (UCMSCs-Exos) can accelerate the healing of skin. MethodsIn our study, UCMSCs were cultured from newborns and Cultured with thrombin. Exosomes were isolated from mesenchymal stem cells culture supernatant by ultracentrifugation. The impact of exosomes on Hacat cell migration was evaluated in vitro. Additionally, the wound healing capacity of exosomes was evaluated in vivo using a mouse skin injury model. ResultsCompared to UCMSCs-Exos, T-UCMSCs-Exos significantly promoted cell proliferation and migration of cells. In vivo experiments demonstrated that T-UCMSCs-Exos can accelerate wound closure and enhance collagen maturation, promoting angiogenesis in the vascularized wound area. These results indicate that T-UCMSCs-Exos have a good potential for accelerating wound healing and minimizing scar formation. ConclusionsOur research indicate that thrombin pre-UCMSCs, the production of exosomes significantly increased. The prepared T-UCMSCs-Exo can accelerate skin wound healing during the process of skin injury repair, promote angiogenesis, and facilitate the reconstruction of epidermis and dermis as well as hair follicle regeneration. These findings demonstrate that T-UCMSCs-Exos for skin wounds are a promising cell-free therapy that can be applied in the treatment of skin injuries.